Semler Scientific (OTCMKTS:SMLR) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday, ValuEngine reports.
OTCMKTS SMLR opened at $43.55 on Friday. The business has a 50 day simple moving average of $41.79 and a 200 day simple moving average of $44.38. Semler Scientific has a 52-week low of $25.50 and a 52-week high of $54.50. The stock has a market cap of $257.85 million, a price-to-earnings ratio of 65.98, a PEG ratio of 1.40 and a beta of 0.38.
Semler Scientific (OTCMKTS:SMLR) last posted its earnings results on Friday, July 26th. The medical equipment provider reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.10. Semler Scientific had a return on equity of 155.19% and a net margin of 27.91%. The business had revenue of $7.95 million during the quarter, compared to analysts’ expectations of $6.72 million. Analysts anticipate that Semler Scientific will post 1.13 EPS for the current fiscal year.
Semler Scientific Company Profile
Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Read More: What is the Current Ratio?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.